Oncology research
belongs here.
PhaseWell Oncology combines experienced investigators, centralized research operations, and community-based patient access to support the successful delivery of oncology clinical trials.
Research begins with trust.
Cancer patients don't start their journey with a clinical trial. They start with a physician.
That continuity is why our sites deliver the enrollment and retention sponsors can count on. When care and trials move together under physicians patients already know and trust, participation holds and data stays clean from first visit to last.
The full breadth of oncology research.
PhaseWell Oncology supports studies across every phase of clinical development, with experience spanning hematologic malignancies, solid tumors, early phase research, precision medicine, and emerging oncology therapies.
Hematologic malignancies
AML, MDS, CLL, CML, lymphoma, and multiple myeloma
Solid tumors
Lung, breast, colorectal, gastrointestinal, genitourinary, and gynecologic cancers
Early phase oncology
First-in-human studies, dose-escalation programs, and Phase I clinical trials
Precision medicine
Biomarker-driven studies, companion diagnostics, molecular profiling, and targeted patient populations
Novel modalities
Antibody-drug conjugates (ADCs), bispecific antibodies, radiopharmaceuticals, and gene therapies
Specialized oncology studies
Rare biomarkers, complex eligibility criteria, and intensive patient monitoring requirements
Decades of oncology research.
One of the nation's most experienced community oncology research organizations, Gabrail Research set the standard every PhaseWell Oncology site is built around: experienced investigators, operational rigor, and deep community roots, proving even the most complex oncology research thrives in community settings.
700+
200+
110+
<45 Days
Oncology's future is community-based.
PhaseWell Oncology believes patients shouldn't have to travel to a major academic center to reach national-caliber clinical research. That level of research belongs in the communities where patients live, and we're committed to making it available in far more of them.
That's why we partner with established, independent oncology practices and invest in the infrastructure serious research demands, from regulatory and contracting to quality systems and data. It's how we help trusted community practices grow, without changing what earned that trust.
Carolina Cancer Research Center
Keith Lerro, MD
Pioneer Research Center
Hamdy Mohtaseb, MD
SSAK Partners
Sumit Sawhney, MD
Since partnering with PhaseWell, our enrollment has increased 10x and we've become so much more efficient that we get to spend more time with our patients.
Looking for an oncology research partner?
From first-in-human studies to late-phase development, PhaseWell Oncology combines experienced investigators, community-based patient access, and operational expertise to support the successful delivery of oncology clinical trials.